Dr. Daniel Z. Lieberman: Hidden Potential of the Unconscious Mind

Thoughts on Record: Podcast of the Ottawa Institute of Cognitive Behavioural Therapy

Comments or feedback? Send us a text!

Dr. Daniel Z. Lieberman returns for an encore discussion on Thoughts on Record to discuss his most recent book Spellbound, which explores the untapped potential of our unconscious minds. In this conversation we cover:

• defining of our conscious and unconscious minds
• why Dr. Lieberman wanted to write this book
• getting to know what wants, needs & agendas our unconscious mind might have
• unpacking the wisdom of fairy tales about the unconscious
• shadow work: what the shadow is, the Jungian notion of shadow work and the value it might have through the lens of your book
• what are archetypes, why do we have/need them and “where” do they reside within the structure of the psyche of the unconscious mind
• the notion of the fascination with someone being perhaps, in part, related to our seeing a universal archetype in that person
• why integration such an important process for adults to engage in
• the gift and burden of awareness
• leveraging the desires of the unconscious as a compass with respect to where to take one’s life
• knowing when we have aligned vs misaligned the will of our unconscious and conscious mind

Daniel Z. Lieberman, MD is a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University, where he has earned awards for both teaching and research. He studied the Great Books at St. John’s College and attended medical school at New York University. He is the coauthor of the international bestseller The Molecule of More, which has been translated into 20 languages, and the author of the recently published, Spellbound: Modern Science, Ancient Magic, and the Hidden Potential of the Unconscious Mind. Dr. Lieberman has published extensively in peer-reviewed journals and leading psychiatric textbooks, and has provided insight on psychiatric topics for the US Department of Health and Human Services, the US Department of Commerce, and the Office of Drug and Alcohol Policy.
https://www.danielzlieberman.com/